Congress of the Société Internationale d'Urologie edition:30th location:Shanghai date:1-5 November 2009
Prostate cancer patients with localized prostate cancer, but with a PSA of more than 100 ng/ml are deemed to harbor systemic disease. For that reason, most of them will receive radiotherapy with hormonal treatment, or hormonal treatment alone. Radical prostatectomy is not considered a valuable treatment option in this situation.
The outcomes of 59 patients with a preoperative PSA ≥100 ng/ml who received radical prostatectomy at eight European institutions were compared with 742 patients with a PSA>20, but <100 ng/ml.